Centaurus Financial, Inc. Vertex Pharmaceuticals Inc Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Centaurus Financial, Inc. holds 1,858 shares of VRTX stock, worth $863,152. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,858

Previous 1,569 18.42%

Holding current value

$863,152

Previous $735,000 17.55%

% of portfolio

0.06%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $132,940 - $146,170	289 Added 18.42%	1,858 $864,000
Q2 2024 Sep 20, 2024	BUY	$392.81 - $485.53 $53,422 - $66,032	136 Added 9.49%	1,569 $735,000
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $347,351 - $380,060	852 Added 146.64%	1,433 $599,000
Q4 2023 Feb 26, 2024	BUY	$343.0 - $410.68 $39,788 - $47,638	116 Added 24.95%	581 $236,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $27,392 - $29,359	81 Added 21.09%	465 $162,000
Q2 2023 Aug 15, 2023	SELL	$314.42 - $351.91 $22,323 - $24,985	-71 Reduced 15.6%	384 $135,000
Q1 2023 May 17, 2023	BUY	$283.23 - $323.1 $13,311 - $15,185	47 Added 11.52%	455 $143,000
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $13,716 - $15,431	-48 Reduced 10.53%	408 $117,000
Q3 2022 Dec 05, 2022	BUY	$273.83 - $305.53 $26,835 - $29,941	98 Added 27.37%	456 $132,000
Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $84,115 - $104,732	358 New	358 $101,000
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $703,837 - $830,009	-3,754 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$207.02 - $241.31 $156,507 - $182,430	-756 Reduced 16.76%	3,754 $807,000
Q4 2020 Jan 25, 2021	BUY	$207.01 - $276.09 $28,360 - $37,824	137 Added 3.13%	4,510 $1.07 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $13,549 - $16,064	-53 Reduced 1.2%	4,373 $1.19 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $716,349 - $939,756	3,177 Added 254.36%	4,426 $1.29 Million
Q1 2020 Apr 21, 2020	BUY	$199.77 - $247.81 $4,195 - $5,204	21 Added 1.71%	1,249 $297,000
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $204,719 - $274,961	1,228 New	1,228 $269,000
Q3 2018 Nov 05, 2018	SELL	$167.73 - $192.74 $39,416 - $45,293	-235 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $34,244 - $39,940	235 New	235 $40,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Vertex Pharmaceuticals Inc Transaction History